Telpinstar Tablet 40/5 mg

Adult dose

The recommended dosage for this medication is one tablet once a day, to be taken with water regardless of meals. It is advised to take it at the same time daily (e.g., in the morning) if possible. 40/5 mg: To be administered to patients whose blood pressure is not adequately controlled with either amlodipine 5 mg or telmisartan 40 mg. 80/5 mg: To be given to patients whose blood pressure is not adequately controlled with either amlodipine 5 mg or this drug 40/5 mg.

Child dose

The safety and efficacy of this drug have not been established in pediatric patients under 18 years old; therefore, its use is not recommended.

This drug may cause serious problems for the fetus or newborn if taken during pregnancy, especially in the second and third trimesters. Therefore, it should not be taken by pregnant women or women who may become pregnant. This medication should not be administered to patients with certain conditions, such as severe liver impairment, severe hypotension, or extremely weak cardiac function. Patients with primary aldosteronism, aortic stenosis, or obstructive hypertrophic cardiomyopathy should use this medication with special caution, and those with compromised liver or kidney function should also take it carefully. During treatment, symptoms such as dizziness or swelling may commonly occur; if these symptoms persist, consultation with a healthcare professional is recommended. Pregnant women should not take this medication, and if pregnancy is confirmed, they should immediately discontinue use and switch to another safe treatment option. This drug lowers blood pressure, so patients with hypotension should check their condition carefully before taking it, and continuously monitor blood pressure changes during use. There is a risk of elevated potassium levels in the blood; therefore, caution is especially warranted when taking potassium supplements or drugs containing potassium, and regular blood tests should be conducted. Patients with poor kidney function may experience worsening renal function when taking this medication; hence, regular blood and kidney function tests should be performed as directed by healthcare professionals. This drug may interact with other medications; therefore, if any other medications are being taken, it is essential to inform healthcare professionals, especially when combined with specific antibiotics, analgesics, or anticoagulants. Caution is advised when driving or operating machinery, as dizziness or drowsiness may occur during medication use. Elderly patients may respond more sensitively to this drug, so dosage adjustments should be made, and careful monitoring is necessary. In the event of overdosage, severe hypotension or cardiac problems may arise; ensure adherence to the prescribed dosage and seek immediate medical attention if overdose is suspected. The safety and efficacy of this drug has not been sufficiently established in children, hence it is not recommended for use in this population. When storing, keep this medication out of reach of children, maintain its original packaging, and ensure it is protected from moisture.

Serious side effects

Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, shedding skin, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by coughing + fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, lightning-like headache, seizures, altered consciousness, visual disturbances, paralysis.

Mild side effects

Dizziness, peripheral edema, upper respiratory tract infections (including pharyngitis and sinusitis), urinary tract infections (including cystitis), anemia, hyperkalemia, hypoglycemia (in diabetic patients), hyponatremia, hyperglycemia, depression, insomnia, anxiety, confusion, drowsiness, migraine, headache, sensory disturbances, fainting, peripheral neuropathy, dysgeusia, tremors, extrapyramidal disorders, muscle rigidity, visual disturbances (including diplopia), dizziness, tinnitus, palpitations, bradycardia, tachycardia.

This drug is sensitive to light; therefore, it should be stored in a container that blocks light. Additionally, it is important to store the medication safely at room temperature, specifically between 1 degree and 30 degrees Celsius.

Appearance

Biconvex oval-shaped dual tablet in white and light blue

Package unit

Tablet/PTP - 30 tablets/PTP [(10 tablets/PTP × 3)]